Many autoimmune disease patients struggle with diagnosis, costs, inattentive care

After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with Hashimoto’s disease, an autoimmune disorder.

Pfizer’s first-ever bispecific antibody Elrexfio holds promise in multiple myeloma

Elrexfio’s higher dosage and limited trials may hinder its ability to rival Tecvayli. Credit: Kateryna Kon via Shutterstock. The US Food and Drug Administration’s recent

August 25, 2023

Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target

Nearly two decades ago, a small company called Amylin Pharmaceuticals saw that its first commercial product, a diabetes treatment targeting receptors of the amylin hormone,

September 5, 2024

Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the U.S. Food and Drug Administration (FDA) – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the

June 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.